Family Care Hospitals Reports Positive Q2 Results, Despite Decline in Net Sales
Family Care Hospitals, a microcap company in the healthcare industry, has reported positive financial results for the second quarter of fiscal year 2024-2025. The company's PBT and PAT have increased significantly, while PBDIT has shown a positive trend. However, Net Sales and EPS have declined, posing challenges for shareholders.
Family Care Hospitals, a microcap company in the hospital and healthcare services industry, has recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.
According to the financial report, Family Care has shown positive performance in the second quarter of the fiscal year 2024-2025. The company's score has improved from -6 to 13 in the last three months.
The key factors contributing to this positive performance include a significant growth in Profit Before Tax less Other Income (PBT) and Profit After Tax (PAT) by 1942.00% and 2388.1% respectively, compared to the same quarter last year. The company's Operating Profit (PBDIT) has also shown a positive trend, with the highest value in the last five quarters.
However, the company's Net Sales for the half-yearly period have declined by -67.78% compared to the previous year, indicating a negative sales trend. Additionally, the company's Earnings per Share (EPS) have also decreased, creating lower earnings for shareholders.
Despite these challenges, Family Care Hospitals has shown promising financial results for the quarter ending September 2024. Investors should keep an eye on the company's performance in the upcoming quarters to make informed decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
